Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells - PubMed (original) (raw)
Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells
Takashi Tsuboi et al. Biochem J. 2003.
Abstract
Glucagon-like peptide-1 (GLP-1) is a potent regulator of glucose-stimulated insulin secretion whose mechanisms of action are only partly understood. In the present paper, we show that at low (3 mM) glucose concentrations, GLP-1 increases the free intramitochondrial concentrations of both Ca(2+) ([Ca(2+)](m)), and ATP ([ATP](m)) in clonal MIN6 beta-cells. Suggesting that cAMP-mediated release of Ca(2+) from intracellular stores is responsible for these effects, increases in [ATP](m) that were induced by GLP-1 were completely blocked by the Rp isomer of adenosine-3',5'-cyclic monophosphothioate (Rp-cAMPS), or by chelation of intracellular Ca(2+). Furthermore, inhibition of Ins(1,4,5) P (3) (IP(3)) receptors with xestospongin C, or application of ryanodine, partially inhibited GLP-1-induced [ATP](m) increases, and the simultaneous blockade of both IP(3) and ryanodine receptors (RyR) completely eliminated the rise in [ATP](m). GLP-1 appeared to prompt Ca(2+)-induced Ca(2+) release through IP(3) receptors via a protein kinase A (PKA)-mediated phosphorylation event, since ryanodine-insensitive [ATP](m) increases were abrogated with the PKA inhibitor, H89. In contrast, the effects of GLP-1 on RyR-mediated [ATP](m) increases were apparently mediated by the cAMP-regulated guanine nucleotide exchange factor cAMP-GEFII, since xestospongin C-insensitive [ATP](m) increases were blocked by a dominant-negative form of cAMP-GEFII (G114E,G422D). Taken together, these results demonstrate that GLP-1 potentiates glucose-stimulated insulin release in part via the mobilization of intracellular Ca(2+), and the stimulation of mitochondrial ATP synthesis.
Similar articles
- Involvement of the ryanodine-sensitive Ca2+ store in GLP-1-induced Ca2+ oscillations in insulin-secreting HIT cells.
Sasaki S, Nakagaki I, Kondo H, Hori S. Sasaki S, et al. Pflugers Arch. 2002 Dec;445(3):342-51. doi: 10.1007/s00424-002-0965-z. Epub 2002 Nov 6. Pflugers Arch. 2002. PMID: 12466936 - New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG. Holz GG. Horm Metab Res. 2004 Nov-Dec;36(11-12):787-94. doi: 10.1055/s-2004-826165. Horm Metab Res. 2004. PMID: 15655710 Free PMC article. - Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets.
Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML. Kwon G, et al. Diabetes. 2004 Dec;53 Suppl 3:S225-32. doi: 10.2337/diabetes.53.suppl_3.s225. Diabetes. 2004. PMID: 15561916 Review. - Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J, Brock B, Schmitz O, Rorsman P. Gromada J, et al. Basic Clin Pharmacol Toxicol. 2004 Dec;95(6):252-62. doi: 10.1111/j.1742-7843.2004.t01-1-pto950502.x. Basic Clin Pharmacol Toxicol. 2004. PMID: 15569269 Review.
Cited by
- Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.
Graaf Cd, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW. Graaf Cd, et al. Pharmacol Rev. 2016 Oct;68(4):954-1013. doi: 10.1124/pr.115.011395. Pharmacol Rev. 2016. PMID: 27630114 Free PMC article. Review. - A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells.
Dai FF, Bhattacharjee A, Liu Y, Batchuluun B, Zhang M, Wang XS, Huang X, Luu L, Zhu D, Gaisano H, Wheeler MB. Dai FF, et al. J Biol Chem. 2015 Oct 9;290(41):25045-61. doi: 10.1074/jbc.M115.648592. Epub 2015 Aug 13. J Biol Chem. 2015. PMID: 26272612 Free PMC article. - Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
Briscoe CP, Peat AJ, McKeown SC, Corbett DF, Goetz AS, Littleton TR, McCoy DC, Kenakin TP, Andrews JL, Ammala C, Fornwald JA, Ignar DM, Jenkinson S. Briscoe CP, et al. Br J Pharmacol. 2006 Jul;148(5):619-28. doi: 10.1038/sj.bjp.0706770. Epub 2006 May 15. Br J Pharmacol. 2006. PMID: 16702987 Free PMC article. - Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.
Rowlands J, Heng J, Newsholme P, Carlessi R. Rowlands J, et al. Front Endocrinol (Lausanne). 2018 Nov 23;9:672. doi: 10.3389/fendo.2018.00672. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30532733 Free PMC article. Review. - Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.
Sebastião I, Candeias E, Santos MS, de Oliveira CR, Moreira PI, Duarte AI. Sebastião I, et al. Front Endocrinol (Lausanne). 2014 Jul 8;5:110. doi: 10.3389/fendo.2014.00110. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25071725 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1998 May 26;95(11):6145-50 - PubMed
- Diabetologia. 1998 Mar;41(3):279-86 - PubMed
- Science. 1998 Jun 12;280(5370):1763-6 - PubMed
- Science. 1998 Dec 18;282(5397):2275-9 - PubMed
- Trends Pharmacol Sci. 1998 Dec;19(12):496-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous